Vimta Labs Ltd share price logo

Vimta Labs Ltd

NSE: VIMTALABS

BSE: 524394

Small Cap

Healthcare Sector

604.00

-12.00

(-1.95%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

What are INDmoney investors doing with Vimta Labs shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-37%

Searches for Vimta Labs on INDmoney have decreased by 37% over the last 30 days.

Average holding period of indmoney investors

24 days

INDmoney investors hold Vimta Labs shares for an average of 24 days.

Key Events for Vimta Labs

Last Dividend Declared

2.00 per share, declared on 06/05/2026

View Dividend History

Vimta Labs Stock Performance

as on September 16, 2026 at 7:42 pm IST

  • Day's Low

    Day's High

    ₹580.00
    ₹619.10
    downward going graph

    3.97%

    Downside

    2.50%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹376.05
    ₹851.00
    downward going graph

    37.74%

    Downside

    40.89%

    Upside

    downward going graph

Vimta Labs share price movements today

Previous Close
₹616.00
Open
₹604.00
Volume
2.34L
Upper Circuit
₹739.20
Lower Circuit
₹492.80
Day's Low - High
₹580.00 - ₹619.10
52 Week Low - High
₹376.05 - ₹851.00

Vimta Labs Historical Returns

1 Month Return
-1.19 %
3 Month Return
+ 14.69 %
1 Year Return
-20.72 %
3 Year Return
+ 128.32 %
5 Year Return
+ 320.05 %

Vimta Labs Fundamentals

as on September 16, 2026 at 2:12 pm IST

Market Cap

₹2,752.71 Cr

Return on Equity (ROE)

18.55

PE Ratio (TTM)

35.25

Return on capital employed (ROCE)

23.21

Industry PE ratio

97.37

Beta (LTM)

1.24

P/B Ratio

3.72

Dividend Yield

0

PEG Ratio

25.45

Quarterly Earnings Growth YOY

11.38

EPS (TTM)

9.25

Book Value

72.1

Vimta Labs Stock Valuation

as on September 16, 2026 at 2:12 pm IST

Vimta Labs in the last 5 years

  • Overview

  • Trends

Lowest (13.87x)

March 20, 2023

Today (35.25x)

September 11, 2026

Industry (97.37x)

September 11, 2026

Highest (53.24x)

September 5, 2025

LowHigh

Today’s Price to Earnings Ratio: 35.25x

Vimta Labs Technical Analysis

Track how Vimta Labs technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Neutral

Overall

Bearish9
Bullish4
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
-0.04
Bearish
CCI (20)
-229.97
Bullish
RSI (14)
48.91
Neutral
Momentum (10)
-0.9
Bullish
ADI (14)
28.69
Bearish
Ultimate Oscillator (7,14,28)
59.31
Neutral

Moving Averages

Name

Value

Action

SMA (20)
603.99
Bearish
EMA (20)
603.82
Bearish
VWMA (20)
603.94
Bearish
SMA (50)
603.5
Bullish
EMA (50)
603.9
Bearish
SMA (200)
606.09
Bearish
EMA (200)
605.27
Bearish
KAMA (200)
604.74
Bearish
DEMA (200)
603.18
Bullish

Vimta Labs Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vimta Labs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY2,752.7164.01%0.0041318
BUY17,278.0815.65%0.573201,875
NA18.42-17.75%0.00124
NA467.162.04%0.6623230
NA9,422.0557.59%0.52-2777

Market expectation of Vimta Labs Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Vimta Labs Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Sales
65.54
74.58
79.69
74.88
84.74
89.92
Other Income
2.04
0.7
0.49
0.69
0.68
5.21
Total Income
67.58
75.28
80.18
75.57
85.43
95.13
Expenses
49.91
52.8
55.27
50.57
56.61
56.84
Operating Profit
15.63
21.78
24.42
24.31
28.13
33.08
Operating Profit Margin %
23.85%
29.2%
30.64%
32.47%
33.2%
36.79%
Profit Before Interest, Tax and Depreciation
17.67
22.48
24.91
25
28.82
38.29
Interest
0.61
0.53
0.53
0.47
0.41
0.58
Depreciation
8.65
8.43
8.09
7.98
8.29
9.81
Profit Before Tax
8.41
13.52
16.29
16.55
20.12
27.9
Tax Paid
2.08
3.39
3.93
4.26
4.88
6.4
Profit After Tax
6.33
10.13
12.35
12.28
15.25
21.5
Total Net profit including share of profit / Loss from associate company
6.33
10.13
12.35
12.28
15.25
21.5
EPS
2.86
3.61
5.58
5.54
6.88
9.65
Actual EPS
2.86
3.61
5.58
5.54
6.88
9.65
Adjusted EPS
1.43
1.81
2.79
2.77
3.44
4.83
Diluted EPS
2.83
3.56
5.51
5.47
6.75
9.56

Vimta Labs Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Sales
180.71
210.68
278.28
318.19
288.6
Other Income
3.02
0.83
1.45
3.44
3.71
Total Income
183.73
211.51
279.73
321.63
292.31
Expenses
150.76
157.72
199.22
223.28
202.36
Operating Profit
29.95
52.96
79.06
94.91
86.24
Operating Profit Margin %
16.57%
25.14%
28.41%
29.83%
29.88%
Profit Before Interest, Tax and Depreciation
32.97
53.79
80.51
98.36
89.95
Interest
3.77
2.17
1.5
2.65
2.1
Depreciation
20.93
23.08
23.33
30.71
33.14
Profit Before Tax
8.27
28.54
55.68
65
54.71
Tax Paid
1.42
7.14
14.36
16.83
13.69
Profit After Tax
6.85
21.41
41.33
48.17
41.01
Total Net profit including share of profit / Loss from associate company
6.85
21.41
41.33
48.17
41.01
EPS
3.1
9.68
18.7
21.77
18.52
Actual EPS
3.1
9.68
18.7
21.77
18.52
Adjusted EPS
1.55
4.84
9.35
10.89
9.26
Diluted EPS
3.1
9.68
18.32
21.35
18.25

Vimta Labs Ltd Cash Flow

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Net Cash from Operating Activities
24.35
37.18
59.07
87.94
60.89
Cash Flow from Investing Activities
-20.84
-31.92
-37.85
-57.27
-76.05
Cash Flow from Financing Activities
-0.67
-4.58
-16.62
-10.99
-1.9
Net Cash Flow
2.84
0.69
4.61
19.7
-17.06

Vimta Labs Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
36.98%
36.92%
36.89%
36.89%
36.76%
36.7%
36.67%
35.99%
35.9%
35.85%
35.67%
DII
1.49%
1.5%
1.49%
0%
1.16%
1.43%
1.42%
0.87%
0.11%
0.14%
0.37%
FII
0%
5.13%
5.16%
3.31%
3.81%
3.66%
3.49%
4.33%
4.59%
4.89%
4.42%
Public
58.66%
56.45%
56.46%
59.8%
58.27%
58.2%
58.42%
58.8%
59.41%
59.12%
59.55%
Total Outstanding Shares
2,21,65,365
2,21,70,583
2,21,70,583
2,21,70,583
2,22,13,279
2,22,34,512
4,45,05,568
4,45,40,820
4,46,35,189
4,46,69,355
4,46,69,355
Total Shareholders
19,957
18,550
19,054
20,114
21,156
26,183
30,829
55,933
54,467
51,623
50,190

Mutual Funds Buying / Exiting Vimta Labs

Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Vimta Labs

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

WhiteOak Capital Pharma and Healthcare Fund Direct Growth

WhiteOak Capital Pharma and Healthcare Fund Direct Growth

₹6.21 Cr

₹0.84 Cr (+15.70%)

0.76%

Bandhan BSE Healthcare Index Fund Direct Growth

Bandhan BSE Healthcare Index Fund Direct Growth

₹0.01 Cr

₹0.00 Cr (+7.16%)

0.06%

Mutual Funds Exiting Vimta Labs

Sorted by largest decrease in holding, month-over-month.

No exiting activity data available right now

No exiting activity data available right now

Vimta Labs Corporate Actions

View detailed summary of the earnings and dividend history of Vimta Labs.

  • Vimta Labs Ltd Earnings Results

    Vimta Labs Ltd’s net profit jumped 53.83% since last year same period to ₹18.89Cr in the Q1 2025-2026. On a quarterly growth basis, Vimta Labs Ltd has generated 3.11% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Vimta Labs Ltd Dividends May,2026

    In the quarter ending March 2026, Vimta Labs Ltd has declared dividend of ₹2.00 per share on 06 May 2026 - translating a dividend yield of 0.32%.

    Read More about Dividends

Indices Featuring Vimta Labs Stock

Check stock indices that include Vimta Labs.

BSE Healthcare

₹50,366.58

-112.23 (0.22%)

Insights on Vimta Labs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 5 quarters, 75.57 Cr → 99.31 Cr (in ₹), with an average increase of 6.5% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 59.12% to 59.55% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 12.28 Cr → 21.5 Cr (in ₹), with an average increase of 24.3% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, VIMTALABS has outperformed top 5 stocks with highest market-cap in Biotechnology & Medical Research

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 0.00% to 0.20% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, VIMTALABS stock has moved up by 49.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Shree Ganesh Remedies Ltd has given 16.4% return, outperforming this stock by 37.1%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 4.89% to 4.42% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 35.85% to 35.67% in Jun 2026 quarter

About Vimta Labs Ltd

Vimta Labs Ltd., founded in 1984, is India's premier contract research and testing organization. They provide a wide range of services to several different industries such as pharmaceutical, biopharmaceutical, food, consumer goods, electronic-electrical, agrochemical, healthcare, medical devices and many others. These services range from drug discovery development, preclinical research, GLP and nonGLP clinical research, cGMP and non-GMP analytical services, preclinical research and testing for medical device companies, contract research and testing for agroscience companies, food testing and analytical development services, clinical diagnostics services, environmental regulatory services and more. Vimta was awarded ISO 9002 certification in 1994 and entered a joint venture in 1997 with ROSTEST Moscow, making an investment of 24 of the total Paidup Capital. In 2002, the Company began offering clinical diagnostics services. In 2020, Vimta acquired 100 Equity Shares of Emtac Laboratories Private Limited, making Emtac a wholly owned subsidiary of the Company. With a goal of expanding operations, they are in the process of constructing a five-times-larger facility in S.P.Biotech Park Genome Valley Hyderabad. By providing comprehensive services, certification and joint ventures, Vimta Labs Ltd. has become India's leading contract research and testing organization.

Revenue: ₹97.56Cr as on June 2025 (Q1 FY26)
Net Profit: ₹18.89Cr as on June 2025 (Q1 FY26)
Listing date: 15 Dec, 2005
Chairperson Name: S P Vasireddi
OrganisationVimta Labs Ltd
IndustryHealthcare
CEOS P Vasireddi
E-voting on sharesClick here to vote

FAQs

What is Vimta Labs share price today?

Vimta Labs share price today stands at ₹604 as on . Vimta Labs share today touched a day high of ₹619.1 and a low of ₹580.

What is the 52 week high and 52 week low range for Vimta Labs share?

Vimta Labs touched a 52 week high of ₹851 and a 52 week low of ₹376.05. Vimta Labs share price today i.e. is trending at ₹604, which is -29.02% down from its 52 week high and 60.62% up from its 52 week low.

What is Vimta Labs's market capitalisation today?

Vimta Labs market capitalisation is ₹2,752.71 Cr as on .

How to buy Vimta Labs shares?

To buy Vimta Labs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for VIMTALABS or Vimta Labs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Vimta Labs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Vimta Labs trading volume today?

Vimta Labs trading volume is 2.34L as on . This means that 2.34L shares of Vimta Labs were bought and sold on the stock market during today's trading session.